ReP USP - Resultado da busca

Artigo de periodico
Acute cardiac and hemodynamic effects of sildenafil on resistant hypertension (2013)
Quinaglia, Thiago; Faria, Ana Paula C. de; Fontana, Vanessa; Barbaro, Natalia R.; Sabbatini, Andréa R.; Sertório, Jonas T.; Demacq, Caroline; Tanus-Santos, José Eduardo; Moreno, Heitor
Source: European Journal of Clinical Pharmacology. Unidade: FMRP
Subjects: HIPERTENSÃO, PURINAS, HEMODINÂMICA, PRESSÃO SANGUÍNEA, FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
QUINAGLIA, Thiago et al. Acute cardiac and hemodynamic effects of sildenafil on resistant hypertension. European Journal of Clinical Pharmacology, v. 69, n. 12, p. 2027-2036, 2013Tradução . . Disponível em: https://doi.org/10.1007/s00228-013-1571-z. Acesso em: 04 maio 2026.
APA
Quinaglia, T., Faria, A. P. C. de, Fontana, V., Barbaro, N. R., Sabbatini, A. R., Sertório, J. T., et al. (2013). Acute cardiac and hemodynamic effects of sildenafil on resistant hypertension. European Journal of Clinical Pharmacology, 69( 12), 2027-2036. doi:10.1007/s00228-013-1571-z
NLM
Quinaglia T, Faria APC de, Fontana V, Barbaro NR, Sabbatini AR, Sertório JT, Demacq C, Tanus-Santos JE, Moreno H. Acute cardiac and hemodynamic effects of sildenafil on resistant hypertension [Internet]. European Journal of Clinical Pharmacology. 2013 ; 69( 12): 2027-2036.[citado 2026 maio 04 ] Available from: https://doi.org/10.1007/s00228-013-1571-z
Vancouver
Quinaglia T, Faria APC de, Fontana V, Barbaro NR, Sabbatini AR, Sertório JT, Demacq C, Tanus-Santos JE, Moreno H. Acute cardiac and hemodynamic effects of sildenafil on resistant hypertension [Internet]. European Journal of Clinical Pharmacology. 2013 ; 69( 12): 2027-2036.[citado 2026 maio 04 ] Available from: https://doi.org/10.1007/s00228-013-1571-z
Artigo de periodico
Sildenafil preserves diastolic relaxation after reduction by L-NAME and increases phosphodiesterase-5 in the intercalated discs of cardiac myocytes and arterioles (2011)
Melo, Silvia Elaine Ferreira; Demacq, Caroline; Lacchini, Silvia ; Krieger, José Eduardo; Cláudia, Maria
Source: Clinics. Unidades: ICB, FM
Subjects: HIPERTENSÃO (ENZIMOLOGIA), IMUNOHISTOQUÍMICA, HEMODINÂMICA, MIÓCITOS DE MÚSCULO LISO, RATOS, MODELOS ANIMAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MELO, Silvia Elaine Ferreira et al. Sildenafil preserves diastolic relaxation after reduction by L-NAME and increases phosphodiesterase-5 in the intercalated discs of cardiac myocytes and arterioles. Clinics, v. 66, n. 7, p. 1253-1258, 2011Tradução . . Disponível em: https://doi.org/10.1590/S1807-59322011000700022. Acesso em: 04 maio 2026.
APA
Melo, S. E. F., Demacq, C., Lacchini, S., Krieger, J. E., & Cláudia, M. (2011). Sildenafil preserves diastolic relaxation after reduction by L-NAME and increases phosphodiesterase-5 in the intercalated discs of cardiac myocytes and arterioles. Clinics, 66( 7), 1253-1258. doi:10.1590/S1807-59322011000700022
NLM
Melo SEF, Demacq C, Lacchini S, Krieger JE, Cláudia M. Sildenafil preserves diastolic relaxation after reduction by L-NAME and increases phosphodiesterase-5 in the intercalated discs of cardiac myocytes and arterioles [Internet]. Clinics. 2011 ; 66( 7): 1253-1258.[citado 2026 maio 04 ] Available from: https://doi.org/10.1590/S1807-59322011000700022
Vancouver
Melo SEF, Demacq C, Lacchini S, Krieger JE, Cláudia M. Sildenafil preserves diastolic relaxation after reduction by L-NAME and increases phosphodiesterase-5 in the intercalated discs of cardiac myocytes and arterioles [Internet]. Clinics. 2011 ; 66( 7): 1253-1258.[citado 2026 maio 04 ] Available from: https://doi.org/10.1590/S1807-59322011000700022
Artigo de periodico
Gene Variation in Resistant Hypertension: Multilocus Analysis of the Angiotensin 1-Converting Enzyme, Angiotensinogen, and Endothelial Nitric Oxide Synthase Genes (2011)
Yugar-Toledo, Juan Carlos; Martin, José Fernando Vilela; Krieger, José Eduardo; Pereira, Alexandre C.; Demacq, Caroline; Coelho, Otávio Rizzi; Pimenta, Eduardo; Calhoun, David A.; Moreno Júnior, Heitor
Source: DNA and Cell Biology. Unidade: FM
Subjects: VARIAÇÃO GENÉTICA, GENÓTIPOS (COMBINAÇÃO), ÓXIDO NÍTRICO, SISTEMA RENINA-ANGIOTENSINA, HIPERTENSÃO (ENZIMOLOGIA;GENÉTICA), POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YUGAR-TOLEDO, Juan Carlos et al. Gene Variation in Resistant Hypertension: Multilocus Analysis of the Angiotensin 1-Converting Enzyme, Angiotensinogen, and Endothelial Nitric Oxide Synthase Genes. DNA and Cell Biology, v. 30, n. 8, p. 555-564, 2011Tradução . . Disponível em: https://doi.org/10.1089/dna.2010.1156. Acesso em: 04 maio 2026.
APA
Yugar-Toledo, J. C., Martin, J. F. V., Krieger, J. E., Pereira, A. C., Demacq, C., Coelho, O. R., et al. (2011). Gene Variation in Resistant Hypertension: Multilocus Analysis of the Angiotensin 1-Converting Enzyme, Angiotensinogen, and Endothelial Nitric Oxide Synthase Genes. DNA and Cell Biology, 30( 8), 555-564. doi:10.1089/dna.2010.1156
NLM
Yugar-Toledo JC, Martin JFV, Krieger JE, Pereira AC, Demacq C, Coelho OR, Pimenta E, Calhoun DA, Moreno Júnior H. Gene Variation in Resistant Hypertension: Multilocus Analysis of the Angiotensin 1-Converting Enzyme, Angiotensinogen, and Endothelial Nitric Oxide Synthase Genes [Internet]. DNA and Cell Biology. 2011 ; 30( 8): 555-564.[citado 2026 maio 04 ] Available from: https://doi.org/10.1089/dna.2010.1156
Vancouver
Yugar-Toledo JC, Martin JFV, Krieger JE, Pereira AC, Demacq C, Coelho OR, Pimenta E, Calhoun DA, Moreno Júnior H. Gene Variation in Resistant Hypertension: Multilocus Analysis of the Angiotensin 1-Converting Enzyme, Angiotensinogen, and Endothelial Nitric Oxide Synthase Genes [Internet]. DNA and Cell Biology. 2011 ; 30( 8): 555-564.[citado 2026 maio 04 ] Available from: https://doi.org/10.1089/dna.2010.1156
Artigo de periodico
Vascular endothelial growth factor (VEGF) and endothelial nitric oxide synthase (NOS3) polymorphisms are associated with high relapse risk in childhood acute lymphoblastic leukemia (ALL) (2010)
Demacq, Caroline; Vasconcellos, Vivian B.; Izidoro-Toledo, Tatiane C.; Silveira, Vanessa da Silva; Canalle, Renata; Queiroz, Rosane Gomes de Paula; Tone, Luiz Gonzaga; Tanus-Santos, José Eduardo
Source: Clinica Chimica Acta. Unidade: FMRP
Subjects: LEUCEMIA, POLIMORFISMO, ENDOTÉLIO VASCULAR, CRIANÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DEMACQ, Caroline et al. Vascular endothelial growth factor (VEGF) and endothelial nitric oxide synthase (NOS3) polymorphisms are associated with high relapse risk in childhood acute lymphoblastic leukemia (ALL). Clinica Chimica Acta, v. 411, n. 17-18, p. 1335-1340, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.cca.2010.05.025. Acesso em: 04 maio 2026.
APA
Demacq, C., Vasconcellos, V. B., Izidoro-Toledo, T. C., Silveira, V. da S., Canalle, R., Queiroz, R. G. de P., et al. (2010). Vascular endothelial growth factor (VEGF) and endothelial nitric oxide synthase (NOS3) polymorphisms are associated with high relapse risk in childhood acute lymphoblastic leukemia (ALL). Clinica Chimica Acta, 411( 17-18), 1335-1340. doi:10.1016/j.cca.2010.05.025
NLM
Demacq C, Vasconcellos VB, Izidoro-Toledo TC, Silveira V da S, Canalle R, Queiroz RG de P, Tone LG, Tanus-Santos JE. Vascular endothelial growth factor (VEGF) and endothelial nitric oxide synthase (NOS3) polymorphisms are associated with high relapse risk in childhood acute lymphoblastic leukemia (ALL) [Internet]. Clinica Chimica Acta. 2010 ; 411( 17-18): 1335-1340.[citado 2026 maio 04 ] Available from: https://doi.org/10.1016/j.cca.2010.05.025
Vancouver
Demacq C, Vasconcellos VB, Izidoro-Toledo TC, Silveira V da S, Canalle R, Queiroz RG de P, Tone LG, Tanus-Santos JE. Vascular endothelial growth factor (VEGF) and endothelial nitric oxide synthase (NOS3) polymorphisms are associated with high relapse risk in childhood acute lymphoblastic leukemia (ALL) [Internet]. Clinica Chimica Acta. 2010 ; 411( 17-18): 1335-1340.[citado 2026 maio 04 ] Available from: https://doi.org/10.1016/j.cca.2010.05.025
Artigo de periodico
A genetic polymorphism of matrix metalloproteinase 9 (MMP-9) affects the changes in circulating MMP-9 levels induced by highly active antiretroviral therapy in HIV patients (2009)
Demacq, Caroline; Vasconcellos, Vivian B; Marcaccini, Andréa Márcia; Gerlach, Raquel Fernanda; Machado, Alcyone Artioli; Santos, José Eduardo Tanus dos
Source: The Pharmacogenomics Journal. Unidades: FORP, FMRP
Subjects: POLIMORFISMO, METALOPROTEINASES, SÍNDROME DE IMUNODEFICIÊNCIA ADQUIRIDA (TERAPIA), FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DEMACQ, Caroline et al. A genetic polymorphism of matrix metalloproteinase 9 (MMP-9) affects the changes in circulating MMP-9 levels induced by highly active antiretroviral therapy in HIV patients. The Pharmacogenomics Journal, v. 9, n. 4, p. 265-273, 2009Tradução . . Disponível em: https://doi.org/10.1038/tpj.2009.13. Acesso em: 04 maio 2026.
APA
Demacq, C., Vasconcellos, V. B., Marcaccini, A. M., Gerlach, R. F., Machado, A. A., & Santos, J. E. T. dos. (2009). A genetic polymorphism of matrix metalloproteinase 9 (MMP-9) affects the changes in circulating MMP-9 levels induced by highly active antiretroviral therapy in HIV patients. The Pharmacogenomics Journal, 9( 4), 265-273. doi:10.1038/tpj.2009.13
NLM
Demacq C, Vasconcellos VB, Marcaccini AM, Gerlach RF, Machado AA, Santos JET dos. A genetic polymorphism of matrix metalloproteinase 9 (MMP-9) affects the changes in circulating MMP-9 levels induced by highly active antiretroviral therapy in HIV patients [Internet]. The Pharmacogenomics Journal. 2009 ; 9( 4): 265-273.[citado 2026 maio 04 ] Available from: https://doi.org/10.1038/tpj.2009.13
Vancouver
Demacq C, Vasconcellos VB, Marcaccini AM, Gerlach RF, Machado AA, Santos JET dos. A genetic polymorphism of matrix metalloproteinase 9 (MMP-9) affects the changes in circulating MMP-9 levels induced by highly active antiretroviral therapy in HIV patients [Internet]. The Pharmacogenomics Journal. 2009 ; 9( 4): 265-273.[citado 2026 maio 04 ] Available from: https://doi.org/10.1038/tpj.2009.13
Artigo de periodico
Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats (2008)
Martinez, Marcio L. L.; Castro, Michele M.; Rizzi, Elen; Fernandes, Karla; Demacq, Caroline; Bendhack, Lusiane Maria; Gerlach, Raquel Fernanda; Tanus-Santos, José Eduardo
Source: European Journal of Pharmacology. Unidades: FCFRP, FORP, FMRP
Subjects: HIPERTENSÃO, DOENÇAS VASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTINEZ, Marcio L. L. et al. Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats. European Journal of Pharmacology, v. 591, n. 1-3, p. 224-230, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2008.06.096. Acesso em: 04 maio 2026.
APA
Martinez, M. L. L., Castro, M. M., Rizzi, E., Fernandes, K., Demacq, C., Bendhack, L. M., et al. (2008). Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats. European Journal of Pharmacology, 591( 1-3), 224-230. doi:10.1016/j.ejphar.2008.06.096
NLM
Martinez MLL, Castro MM, Rizzi E, Fernandes K, Demacq C, Bendhack LM, Gerlach RF, Tanus-Santos JE. Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats [Internet]. European Journal of Pharmacology. 2008 ; 591( 1-3): 224-230.[citado 2026 maio 04 ] Available from: https://doi.org/10.1016/j.ejphar.2008.06.096
Vancouver
Martinez MLL, Castro MM, Rizzi E, Fernandes K, Demacq C, Bendhack LM, Gerlach RF, Tanus-Santos JE. Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats [Internet]. European Journal of Pharmacology. 2008 ; 591( 1-3): 224-230.[citado 2026 maio 04 ] Available from: https://doi.org/10.1016/j.ejphar.2008.06.096
Artigo de periodico
Inverse relationship between markers of nitric oxide formation and plasma matrix metalloproteinase-9 levels in healthy volunteers (2008)
Demacq, Caroline; Metzger, Ingrid F.; Gerlach, Raquel Fernanda; Tanus-Santos, José Eduardo
Source: Clinica Chimica Acta. Unidades: FORP, FMRP
Subjects: ÓXIDO NÍTRICO, METALOPROTEINASES, SISTEMA CARDIOVASCULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DEMACQ, Caroline et al. Inverse relationship between markers of nitric oxide formation and plasma matrix metalloproteinase-9 levels in healthy volunteers. Clinica Chimica Acta, v. 394, n. 1-2, p. 72-76, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.cca.2008.04.008. Acesso em: 04 maio 2026.
APA
Demacq, C., Metzger, I. F., Gerlach, R. F., & Tanus-Santos, J. E. (2008). Inverse relationship between markers of nitric oxide formation and plasma matrix metalloproteinase-9 levels in healthy volunteers. Clinica Chimica Acta, 394( 1-2), 72-76. doi:10.1016/j.cca.2008.04.008
NLM
Demacq C, Metzger IF, Gerlach RF, Tanus-Santos JE. Inverse relationship between markers of nitric oxide formation and plasma matrix metalloproteinase-9 levels in healthy volunteers [Internet]. Clinica Chimica Acta. 2008 ; 394( 1-2): 72-76.[citado 2026 maio 04 ] Available from: https://doi.org/10.1016/j.cca.2008.04.008
Vancouver
Demacq C, Metzger IF, Gerlach RF, Tanus-Santos JE. Inverse relationship between markers of nitric oxide formation and plasma matrix metalloproteinase-9 levels in healthy volunteers [Internet]. Clinica Chimica Acta. 2008 ; 394( 1-2): 72-76.[citado 2026 maio 04 ] Available from: https://doi.org/10.1016/j.cca.2008.04.008
Artigo de periodico
Functional polymorphisms in the promoter of the matrix metalloproteinase-9 (MMP-9) gene are not linked with significant plasma MMP-9 variations in healthy subjects (2008)
Demacq, Caroline; Vasconcellos, Vivian B.; Marcaccini, Andrea M.; Gerlach, Raquel Fernanda; Silva Júnior, Wilson Araújo da; Tanus-Santos, José Eduardo
Source: Clinical Chemistry and Laboratory Medicine. Unidades: FORP, FMRP
Subjects: POLIMORFISMO, METALOPROTEINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DEMACQ, Caroline et al. Functional polymorphisms in the promoter of the matrix metalloproteinase-9 (MMP-9) gene are not linked with significant plasma MMP-9 variations in healthy subjects. Clinical Chemistry and Laboratory Medicine, v. 46, n. 1, p. 57-63, 2008Tradução . . Disponível em: https://doi.org/10.1515/cclm.2008.014. Acesso em: 04 maio 2026.
APA
Demacq, C., Vasconcellos, V. B., Marcaccini, A. M., Gerlach, R. F., Silva Júnior, W. A. da, & Tanus-Santos, J. E. (2008). Functional polymorphisms in the promoter of the matrix metalloproteinase-9 (MMP-9) gene are not linked with significant plasma MMP-9 variations in healthy subjects. Clinical Chemistry and Laboratory Medicine, 46( 1), 57-63. doi:10.1515/cclm.2008.014
NLM
Demacq C, Vasconcellos VB, Marcaccini AM, Gerlach RF, Silva Júnior WA da, Tanus-Santos JE. Functional polymorphisms in the promoter of the matrix metalloproteinase-9 (MMP-9) gene are not linked with significant plasma MMP-9 variations in healthy subjects [Internet]. Clinical Chemistry and Laboratory Medicine. 2008 ; 46( 1): 57-63.[citado 2026 maio 04 ] Available from: https://doi.org/10.1515/cclm.2008.014
Vancouver
Demacq C, Vasconcellos VB, Marcaccini AM, Gerlach RF, Silva Júnior WA da, Tanus-Santos JE. Functional polymorphisms in the promoter of the matrix metalloproteinase-9 (MMP-9) gene are not linked with significant plasma MMP-9 variations in healthy subjects [Internet]. Clinical Chemistry and Laboratory Medicine. 2008 ; 46( 1): 57-63.[citado 2026 maio 04 ] Available from: https://doi.org/10.1515/cclm.2008.014
Artigo de periodico
Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma (2007)
Gerlach, Raquel Fernanda; Demacq, Caroline; Jung, Klaus; Tanus-Santos, José Eduardo
Source: Clinical Biochemistry. Unidades: FORP, FMRP
Assunto: METALOPROTEINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GERLACH, Raquel Fernanda et al. Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma. Clinical Biochemistry, v. 40, p. 119-123, 2007Tradução . . Disponível em: https://doi.org/10.1016/j.clinbiochem.2006.10.007. Acesso em: 04 maio 2026.
APA
Gerlach, R. F., Demacq, C., Jung, K., & Tanus-Santos, J. E. (2007). Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma. Clinical Biochemistry, 40, 119-123. doi:10.1016/j.clinbiochem.2006.10.007
NLM
Gerlach RF, Demacq C, Jung K, Tanus-Santos JE. Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma [Internet]. Clinical Biochemistry. 2007 ; 40 119-123.[citado 2026 maio 04 ] Available from: https://doi.org/10.1016/j.clinbiochem.2006.10.007
Vancouver
Gerlach RF, Demacq C, Jung K, Tanus-Santos JE. Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma [Internet]. Clinical Biochemistry. 2007 ; 40 119-123.[citado 2026 maio 04 ] Available from: https://doi.org/10.1016/j.clinbiochem.2006.10.007
Artigo de periodico
Genetic polymorphism of matrix metalloproteinase (MMP)-9 does not affect plasma activity in healthy subjects (2006)
Demacq, Caroline; Souza, Ana P. de; Machado, Alcyone Artioli; Gerlach, Raquel Fernanda; Tanus-Santos, José Eduardo
Source: Clinica Chimica Acta. Unidades: FMRP, FORP
Subjects: POLIMORFISMO, ELETROFORESE, METALOPROTEINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DEMACQ, Caroline et al. Genetic polymorphism of matrix metalloproteinase (MMP)-9 does not affect plasma activity in healthy subjects. Clinica Chimica Acta, v. 365, n. 1-2, p. 183-187, 2006Tradução . . Disponível em: https://doi.org/10.1016/j.cca.2005.08.017. Acesso em: 04 maio 2026.
APA
Demacq, C., Souza, A. P. de, Machado, A. A., Gerlach, R. F., & Tanus-Santos, J. E. (2006). Genetic polymorphism of matrix metalloproteinase (MMP)-9 does not affect plasma activity in healthy subjects. Clinica Chimica Acta, 365( 1-2), 183-187. doi:10.1016/j.cca.2005.08.017
NLM
Demacq C, Souza AP de, Machado AA, Gerlach RF, Tanus-Santos JE. Genetic polymorphism of matrix metalloproteinase (MMP)-9 does not affect plasma activity in healthy subjects [Internet]. Clinica Chimica Acta. 2006 ; 365( 1-2): 183-187.[citado 2026 maio 04 ] Available from: https://doi.org/10.1016/j.cca.2005.08.017
Vancouver
Demacq C, Souza AP de, Machado AA, Gerlach RF, Tanus-Santos JE. Genetic polymorphism of matrix metalloproteinase (MMP)-9 does not affect plasma activity in healthy subjects [Internet]. Clinica Chimica Acta. 2006 ; 365( 1-2): 183-187.[citado 2026 maio 04 ] Available from: https://doi.org/10.1016/j.cca.2005.08.017

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Countries/Territories

Indexado em